Cargando…

Analysis of the Mechanisms of Action of Naphthoquinone-Based Anti-Acute Myeloid Leukemia Chemotherapeutics

Acute myeloid leukemia (AML) is a neoplastic disorder resulting from clonal proliferation of poorly differentiated immature myeloid cells. Distinct genetic and epigenetic aberrations are key features of AML that account for its variable response to standard therapy. Irrespective of their oncogenic m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Michelle H., Lapidus, Rena G., Ferraris, Dana, Emadi, Ashkan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749238/ https://www.ncbi.nlm.nih.gov/pubmed/31466259 http://dx.doi.org/10.3390/molecules24173121

Ejemplares similares

A direct interaction between NQO1 and a chemotherapeutic dimeric naphthoquinone
por: Pidugu, Lakshmi Swarna Mukhi, et al.
Publicado: (2016)

Hydroxylated Dimeric Naphthoquinones Increase the Generation of Reactive Oxygen Species, Induce Apoptosis of Acute Myeloid Leukemia Cells and Are Not Substrates of the Multidrug Resistance Proteins ABCB1 and ABCG2
por: Lapidus, Rena G., et al.
Publicado: (2016)

1-C Metabolism—Serine, Glycine, Folates—In Acute Myeloid Leukemia
por: Mahmood, Kanwal, et al.
Publicado: (2021)

Chemotherapeutic Resistance in Egyptian Acute Myeloid Leukemia Patients
por: Kassem, Neemat M, et al.
Publicado: (2019)

A Chemical Genetic Screen for Modulators of Asymmetrical 2,2′-Dimeric Naphthoquinones Cytotoxicity in Yeast
por: Emadi, Ashkan, et al.
Publicado: (2010)

Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia
por: Sorrentino, Vincent G., et al.
Publicado: (2021)

The Naphthoquinone Diospyrin Is an Inhibitor of DNA Gyrase with a Novel Mechanism of Action
por: Karkare, Shantanu, et al.
Publicado: (2013)

Minimally-Myelosuppressive Asparaginase-Containing Induction Regimen for Treatment of a Jehovah’s Witness with mutant IDH1/NPM1/NRAS Acute Myeloid Leukemia
por: Emadi, Ashkan, et al.
Publicado: (2016)

High expression of neuroguidin increases the sensitivity of acute myeloid leukemia cells to chemotherapeutic drugs
por: Chen, Kejun, et al.
Publicado: (2015)

Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target
por: Holtzman, Noa G., et al.
Publicado: (2021)

The diverse mechanisms and anticancer potential of naphthoquinones
por: Pereyra, Carolina Escardó, et al.
Publicado: (2019)

Natural Products and Acute Myeloid Leukemia: A Review Highlighting Mechanisms of Action
por: Hwang, Dongwon, et al.
Publicado: (2019)

Mechanism of Action of Decitabine in the Treatment of Acute Myeloid Leukemia by Regulating LINC00599
por: Du, Fan, et al.
Publicado: (2023)

A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia
por: Saland, E, et al.
Publicado: (2015)

Antifungal activity of synthetic naphthoquinones against dermatophytes and opportunistic fungi: preliminary mechanism-of-action tests
por: Ferreira, Maria do Perpetuo Socorro Borges Carriço, et al.
Publicado: (2014)

MicroRNA-181a enhances the chemotherapeutic sensitivity of chronic myeloid leukemia to imatinib
por: WANG, GUANGYU, et al.
Publicado: (2015)

Detection of anti-Toxoplasma gondii antibodies in chronic myeloid leukemia and acute myeloid leukemia patients
por: Gharavi, Mohammad Javad, et al.
Publicado: (2017)

Amino alkynylisoquinoline and alkynylnaphthyridine compounds potently inhibit acute myeloid leukemia proliferation in mice
por: Naganna, N., et al.
Publicado: (2019)

Impact of FLT3-ITD Insertion Length on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study
por: Corley, Elizabeth M., et al.
Publicado: (2022)

1,4-Naphthoquinone Analogues: Potent Antibacterial Agents and Mode of Action Evaluation
por: Ravichandiran, Palanisamy, et al.
Publicado: (2019)

Mechanisms of drug resistance in acute myeloid leukemia
por: Zhang, Jing, et al.
Publicado: (2019)

Improving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4/CXCL12 axis
por: Li, Xiaojin, et al.
Publicado: (2015)

Successful Outcomes of Children Simultaneously Diagnosed with Acute Myeloid Leukemia and Covid-19: The Role of a Mild Chemotherapeutic Induction Regimen
por: Lins, Mecneide Mendes, et al.
Publicado: (2020)

Construction of Genetically Encoded Biosensors to Monitor Subcellular Compartment-Specific Glutathione Response to Chemotherapeutic Drugs in Acute Myeloid Leukemia Cells
por: Abbas, Ghulam, et al.
Publicado: (2023)

Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study
por: Mustafa Ali, Moaath K., et al.
Publicado: (2022)

Impact of IDH1 c.315C>T SNP on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study
por: Corley, Elizabeth M., et al.
Publicado: (2022)

Aldehyde Dehydrogenase Genes as Prospective Actionable Targets in Acute Myeloid Leukemia
por: Dancik, Garrett M., et al.
Publicado: (2023)

Reverse Pseudohyperkalemia: An Important Clinical Entity in Chronic Lymphocytic Leukemia
por: Mansoor, Sahar, et al.
Publicado: (2015)

Cytotoxicity Mechanism of Two Naphthoquinones (Menadione and Plumbagin) in Saccharomyces cerevisiae
por: Castro, Frederico Augusto Vieira, et al.
Publicado: (2008)

Chemotherapeutic targeting of myeloid-derived suppressor cells
por: Alizadeh, Darya, et al.
Publicado: (2014)

The Bone Marrow Microenvironment Mechanisms in Acute Myeloid Leukemia
por: Pimenta, Débora Bifano, et al.
Publicado: (2021)

Mechanisms of Resistance to Small Molecules in Acute Myeloid Leukemia
por: Lang, Tonio Johannes Lukas, et al.
Publicado: (2023)

Anti-Tumor Effects of BDH1 in Acute Myeloid Leukemia
por: Han, Fei, et al.
Publicado: (2021)

Acute Myeloid Leukemia
Publicado: (2019)

Acute myeloid leukemia
por: Haferlach, Torsten
Publicado: (2019)

Acute myeloid leukemia
por: Ossenkoppele, Gert
Publicado: (2018)

Frontline Blinatumomab in Older Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia
por: Niyongere, Sandrine, et al.
Publicado: (2020)

PB2498: A PHASE 1 STUDY OF WU-NK-101 IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)
por: Cashen, Amanda, et al.
Publicado: (2023)

Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells
por: Li, Yin, et al.
Publicado: (2017)

Cyanobacteria-specific algicidal mechanism of bioinspired naphthoquinone derivative, NQ 2-0
por: Lee, Heon Woo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tr3kvu8h4qeeh20qvnq69ln4ni